PHENYLKETONURIA
Clinical trials for PHENYLKETONURIA explained in plain language.
Never miss a new study
Get alerted when new PHENYLKETONURIA trials appear
Sign up with your email to follow new studies for PHENYLKETONURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered probiotic shows promise for PKU in small early trial
Disease control CompletedThis early-phase study tested an engineered probiotic (CBT102-A) in 15 children aged 3–17 with phenylketonuria (PKU), a genetic condition that makes it hard to break down an amino acid called phenylalanine. For 20 days, 10 children received the probiotic and 5 received a placebo.…
Matched conditions: PHENYLKETONURIA
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
PKU Patients' hidden inflammation revealed in new study
Knowledge-focused CompletedThis study looked at whether adults with phenylketonuria (PKU) have low-level inflammation throughout their bodies. Researchers measured inflammatory markers in the blood of 40 participants, including both PKU patients and healthy volunteers. The goal was to better understand how…
Matched conditions: PHENYLKETONURIA
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC